Requests that the Commissioner take action consistent with Congress' enactment of the Federal Food, Drug, and Cosmetic Act ("FDCA") and the Food and Drug Omnibus Reform Act of 2022 ("FDORA") and amend its regulations and guidance documents to clarify the requirements for approval of drugs for the benefit of the regulated community, including the acceptance of data from new alternative methods